Abstract:Piperine, a bioactive alkaloid exhibits anticancer mechanisms by inducing apoptosis, inhibiting cancer cell proliferation and preventing metastasis. It disrupts tumor progression by targeting tumor precursor cells and blocking unregulated cell growth, highlighting its therapeutic potential as an anticancer agent. Anticancer drug discovery needs serious attention to overcome the high mortality rate caused by cancer. There are still many obstacles to treating this disease, such as the high cost of chemotherapeutic drugs, the resulting side effects from the drug, and the occurrence of multidrug resistance. Herbaceous plants are a reservoir of natural compounds that can be anticancer drugs with novel mechanisms of action. Piperine, a bioactive compound derived from Piper species, is gaining attention due to its unique dual role in directly inhibiting tumor growth and enhancing the bioavailability of chemotherapeutic drugs. Unlike conventional treatments, Piperine exhibits a novel mechanism of action by modulating multiple signaling pathways, including apoptosis and autophagy, with low toxicity. Additionally, Piperine acts as a bioenhancer by improving the absorption and effectiveness of other anticancer agents, reducing the required dosage, and minimizing side effects. Therefore, this review aims to visualize a summary of Piperine sources, phytochemistry, chemical structure–anticancer activity relationship, anticancer activities of semi‐synthetic derivatives, pharmacokinetic and bioavailability, in vitro and in vivo preclinical studies, mechanism of antitumor action, human clinical trials, toxicity, side effects, and safety of Piperine. References were collected from the Pubmed/MedLine database (https://pubmed.ncbi.nlm.nih.gov/) with the following keywords: "Piperine anticancer," "Piperine derivatives," "Piperine antitumor mechanism" and "Piperine pharmacokinetic and bioavailability," after filter process by inclusion and exclusion criteria, 101 were selected from 444 articles. From 2013 to 2023, there were numerous studies regarding preclinical studies of Piperine of various cell lines, including breast cancer, prostate cancer, lung cancer, melanoma, cervical cancer, gastric cancer, osteosarcoma, colon cancer, hepatocellular carcinoma, ovarian cancer, leukemia, colorectal cancer, and hypopharyngeal carcinoma. In vivo, the anticancer study has also been conducted on some animal models, such as Ehrlich carcinoma‐bearing mice, Ehrlich ascites carcinoma cells‐bearing Balbc mice, hepatocellular carcinoma‐bearing Wistar rat, A375SM cells‐bearing mice, A375P cells‐bearing mice, SNU‐16 cells‐bearing BalbC mice, and HGC‐27‐bearing baby mice. Treatment with this compound leads to cell proliferation inhibition and induction of apoptosis. Piperine has been used for clinical trials of diseases, but no cancer patient report exists. Various semi‐synthetic derivatives of Piperine show efficacy as an anticancer drug across multiple cell lines. Piperine shows promise for use in cancer clinical trials, either as a standalone treatment or as a bioenhancer. Its bioenhancer properties may enhance the efficacy of existing chemotherapeutic agents, providing a valuable foundation for developing new anticancer therapies.

Design, Synthesis and Biological Evaluation of Piperine Derivatives As Potent Antitumor Agents

Design, Synthesis, and Antiproliferative Evaluation of Piperine Derivatives

Design, synthesis, and evaluation of benzodioxolane compounds for antitumor activity

Design,Synthesis and Anti-cervical Cancer Activity of Piperine-bicycloamide Derivatives

Piperine Suppresses Tumor Growth and Metastasis in Vitro and in Vivo in a 4T1 Murine Breast Cancer Model

Synthesis and antiproliferative evaluation of new hybrids of piperine and acylhydrazone

Design, Synthesis and Biological Activity of Piperlongumine Derivatives As Selective Anticancer Agents.

Design, synthesis and antitumor activity evaluation of pyrimidine derivatives containing 4-hydroxypiperidine group

Synthesis and Antitumor Activity of Tetrahydroimidazo[2′,1′:2,3]thiazolo [5,4-C]piperdine Derivatives

Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents

Design, Synthesis and Preliminary Biological Evaluation of 5,8-Dihydropteridine-6,7-diones That Induce Apoptosis and Suppress Cell Migration

Synthesis, anticancer evaluation, preliminary mechanism study of novel 1, 2, 3-triazole-piperlongumine derivatives

Piperine: an emerging biofactor with anticancer efficacy and therapeutic potential

Syntheses and Antitumor Activities of Phenylpiperazine Derivatives

Design, Synthesis, and Biological Evaluation of Matrine Derivatives Possessing Piperazine Moiety As Antitumor Agents

Synthesis and Biological Evaluation of Piperazine Group-Linked Bivalent Beta-Carbolines As Potential Antitumor Agents

SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF 1,4 BIS[3- (AMINO-DITHIOCARBOXY)PROPIONYL] PIPERAZINE DERIVATIVES

Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines

Design, Synthesis and Biological Evaluation of Novel 7-Amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-Aminotetrazolo[1,5-f]pteridinone Derivative As Potent Antitumor Agents

Design and Synthesis of 1-(6-(2-(2-arylethynyl)phenyl)hexyn-5-yl)piperidin-2-ones As Antitumor Agents That Induce Apoptotic Progress

Piperine Functions As a Tumor Suppressor for Human Ovarian Tumor Growth Via Activation of JNK/p38 MAPK-mediated Intrinsic Apoptotic Pathway